1 2 3


CADET was established to employ mass-spectrometric-based analysis of trace elements, metabolites (metabolomics) and proteins (proteomics) to identify and developing new and improved therapeutics. This is done by investigating the molecular mechanisms of chronic non-communicable diseases. Our main disease targets are:

  • diabetes mellitus and its complications;
  • chronic cardiovascular diseases;
  • adult-onset dementia, particularly Alzheimer’s disease;
  • age-related macular degeneration (AMD).

See further introductory information (pdf PDF 183 KB)